Search judgments by proposition, citation, court, judge or legal topic, then move directly into the source-grounded case analysis.
Results update automatically as you type.
Canada decisions
Decisions matching the current search
The Federal Court removed an SEO designation from the defendant's manufacturer identity, finding the defendant had not shown on a balance of probabilities that disclosure could cause harm.
The Federal Court allowed Richards’ appeal in part, validating C-CEO designations for four documents and rejecting Distrimedic’s cross-motion for de novo reconsideration.
The Federal Court validated C-CEO designations for sensitive discovery documents, upheld related sealing orders, and awarded the defendants $3,000 in costs.
The court held asylum and refugee applications could remain confidential, expanded access to documents for certain witnesses and the defendant, and ordered review of redactions.
Motion granted in a copyright infringement action: leave to amend pleadings, production of client-related documents under a protective order, and continuation of discovery were ordered.
Appeal from a prothonotary’s refusal to vary a confidentiality order was dismissed because no change in circumstances or compelling reason was shown.
The Federal Court allowed Apotex to use a confidential patent application and its prosecution history in a proposed notice of allegation, and varied the protective order.
Application refused on discretionary grounds: the chambers judge declined to decide the discovery and relevance disputes and referred the matters to Justice Scanlan because the issues were closely linked to Scanlan J.'s earlier decision, a decision on relevance/confidentiality would be premature before a determination of liability, and there was a risk of contradicting the earlier judge; severance and confidentiality processes should be addressed by Scanlan J.
Source excerpt
The Federal Court varied a prior protective order so AstraZeneca could use confidential material from earlier proceedings in a related judicial review, subject to new confidentiality protections.
The Federal Court granted a confidentiality order for licensing, pricing, technical, and royalty documents, finding disclosure could harm the plaintiffs’ commercial interests.
Explore more
